Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Gyan

Showing results (71-80 of 174) with videos related to

Pageof 18
Sort By:
Blood Advances|October 27, 2020
Horizontal meta-analysis identifies common deregulated genes across AML subgroups providing a robust prognostic signatureAli Nehme, Hassan Dakik, Frédéric Picou, et al.
Annals of Hematology|January 8, 2020
Hypercalcemia is associated with a poor prognosis in lymphoma a retrospective monocentric matched-control study and extensive review of published reported casesNicolas Vallet, Marjan Ertault, Jean-Baptiste Delaye, et al.
Bulletin Du Cancer|July 28, 2023
[Creating a community of heads of department to meet hospital system challenges: First experience in haematology]Roch Houot, Jacques-Olivier Bay, Patrice Chevallier, et al.
Medicine|July 3, 2004
Pseudouveitis: a clue to the diagnosis of primary central nervous system lymphoma in immunocompetent patientsSophie Park, Sébastien Abad, Micheline Tulliez, et al.
Annals of Hematology|November 27, 2025
Length of hospital stay and outcome in primary central nervous system lymphoma: a French retrospective multicentric studyRaphaël Maguet, Martin Eloit, Olivier Chinot, et al.
Cancer|February 13, 2025
Maintenance therapy with the FMS-like tyrosine kinase 3 inhibitor gilteritinib in patients with FMS-like tyrosine kinase 3-internal tandem duplication acute myeloid leukemia: A phase 2 studyEmmanuel Gyan, Mark D Minden, Kohmei Kubo, et al.
Cancer Gene Therapy|February 23, 2022
Aberrant DNA methylation impacts HOX genes expression in bone marrow mesenchymal stromal cells of myelodysplastic syndromes and de novo acute myeloid leukemiaBenjamin Roux, Frédéric Picou, Christelle Debeissat, et al.
European Journal of Haematology|May 3, 2018
Prospective evaluation of the effect of deferasirox on hematologic response in transfusion-dependent patients with low-risk MDS and iron overloadChristian Rose, Caroline Lenoir, Emmanuel Gyan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 21, 2026
Infectious events in fit patients with relapsed or refractory acute myeloid leukemia treated with azacitidine-venetoclax or intensive chemotherapyMaxime Bobo, Lucas Lefevre, Paul Mallet-Guy, et al.
Blood Advances|August 8, 2020
High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteersHélène Guermouche, Noémie Ravalet, Nathalie Gallay, et al.
Pageof 18

Showing results (71-80 of 174) with videos related to

Sort By:
Pageof 18
Blood Advances|October 27, 2020
Horizontal meta-analysis identifies common deregulated genes across AML subgroups providing a robust prognostic signatureAli Nehme, Hassan Dakik, Frédéric Picou, et al.
Annals of Hematology|January 8, 2020
Hypercalcemia is associated with a poor prognosis in lymphoma a retrospective monocentric matched-control study and extensive review of published reported casesNicolas Vallet, Marjan Ertault, Jean-Baptiste Delaye, et al.
Bulletin Du Cancer|July 28, 2023
[Creating a community of heads of department to meet hospital system challenges: First experience in haematology]Roch Houot, Jacques-Olivier Bay, Patrice Chevallier, et al.
Medicine|July 3, 2004
Pseudouveitis: a clue to the diagnosis of primary central nervous system lymphoma in immunocompetent patientsSophie Park, Sébastien Abad, Micheline Tulliez, et al.
Annals of Hematology|November 27, 2025
Length of hospital stay and outcome in primary central nervous system lymphoma: a French retrospective multicentric studyRaphaël Maguet, Martin Eloit, Olivier Chinot, et al.
Cancer|February 13, 2025
Maintenance therapy with the FMS-like tyrosine kinase 3 inhibitor gilteritinib in patients with FMS-like tyrosine kinase 3-internal tandem duplication acute myeloid leukemia: A phase 2 studyEmmanuel Gyan, Mark D Minden, Kohmei Kubo, et al.
Cancer Gene Therapy|February 23, 2022
Aberrant DNA methylation impacts HOX genes expression in bone marrow mesenchymal stromal cells of myelodysplastic syndromes and de novo acute myeloid leukemiaBenjamin Roux, Frédéric Picou, Christelle Debeissat, et al.
European Journal of Haematology|May 3, 2018
Prospective evaluation of the effect of deferasirox on hematologic response in transfusion-dependent patients with low-risk MDS and iron overloadChristian Rose, Caroline Lenoir, Emmanuel Gyan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 21, 2026
Infectious events in fit patients with relapsed or refractory acute myeloid leukemia treated with azacitidine-venetoclax or intensive chemotherapyMaxime Bobo, Lucas Lefevre, Paul Mallet-Guy, et al.
Blood Advances|August 8, 2020
High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteersHélène Guermouche, Noémie Ravalet, Nathalie Gallay, et al.
Pageof 18